<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139655">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02038582</url>
  </required_header>
  <id_info>
    <org_study_id>44549-A</org_study_id>
    <nct_id>NCT02038582</nct_id>
  </id_info>
  <brief_title>Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa</brief_title>
  <official_title>An Evaluation of Strategies to Increase Testing and Linkages of HIV Positive Individuals to Care and HIV Negative Men to Male Circumcision in Sub-Saharan Africa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <authority>Uganda: National Council for Science and Technology</authority>
    <authority>Uganda: Research Ethics Committee</authority>
    <authority>Uganda: Ministry of Health</authority>
    <authority>South Africa: Human Sciences Research Council</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine efficient, scalable, evidence-based strategies to
      link HIV positive individuals to care and HIV negative individuals to prevention measures,
      such as voluntary male circumcision.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      New strategies for HIV testing and linkages to care are needed, since only a minority of
      African adults have been tested in many settings and a drop-off occurs at each step from HIV
      and CD4 testing, remaining in pre-ART (antiretroviral therapy) care, ART initiation, and
      adherence over the long term.

      This study aims to determine the effects of Point-of-Care (POC) CD4 testing, POC viral load
      (VL) testing and several linkage strategies (lay-counselor follow-up, accompaniment to HIV
      clinic by lay counselor, or clinical referral) on linkage to care and treatment adherence
      for HIV positive persons.

      This study also aims to determine the uptake of voluntary circumcision among HIV uninfected
      males with either promotion at point of HIV testing, Short Message Service (SMS)  follow-up
      or lay counselor follow-up visits.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Linkage to care for HIV infected persons not on treatment following a point-of care CD4 count compared to referral to clinic for CD4 testing</measure>
    <time_frame>Up to 12 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Proportion of HIV positive individuals in the POC CD4 arm who visit a clinic, obtain a staging CD4 test, initiate ART if eligible, or have a viral load &lt;50 copies/mL within 9 months compared to those in the clinic referral arm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Uptake of male circumcision referral among HIV-uninfected men  with either promotion at point of HIV testing, SMS follow-up or lay-counselor follow-up visits</measure>
    <time_frame>Up to 9 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Proportion of HIV-uninfected men who visit a male circumcision clinic or outreach venue for information about circumcision and proportion who report being circumcised by month 3 and 9 in the lay-counselor arm compared to the SMS follow-up arm, and male circumcision promotion at HIV testing arm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Linkage to care for HIV infected persons after lay counselor follow-up, accompaniment to HIV clinic by lay counselor, or clinic referral</measure>
    <time_frame>Up to 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Proportion of HIV positive individuals not on ART at baseline who visit a clinic, obtain a staging CD4 test,  initiate ART if eligible, or have a viral load &lt;50 copies/mL within 9 months in the lay counselor follow-up arm compared to the accompaniment and clinic referral arms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>POC viral load testing impact on ART adherence and viral suppression compared to standard laboratory testing</measure>
    <time_frame>Up to 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Proportion of HIV positive persons with  viral load &lt;50 copies/mL at 3 months among those who receive POC viral load testing compared to those participants who receive standard laboratory-based viral load testing.</description>
  </secondary_outcome>
  <number_of_arms>11</number_of_arms>
  <enrollment type="Anticipated">13000</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>POC CD4 &amp; Clinic Accompaniment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV positive persons not on ART at enrollment, randomized to POC CD4 testing and follow up with clinic accompaniment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>POC CD4 &amp; Lay Counselor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV positive persons not on ART at enrollment, randomized to POC CD4 testing and lay counselor follow up</description>
  </arm_group>
  <arm_group>
    <arm_group_label>POC CD4 &amp; Clinic Referral</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV positive persons not on ART at enrollment, randomized to POC CD4 testing and referral to clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CD4 Referral &amp; Clinic Accompaniment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV positive persons not on ART at enrollment, randomized to referral for CD4 testing and follow up with clinic accompaniment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CD4 Referral &amp; Lay Counselor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV positive persons not on ART at enrollment, randomized to referral for CD4 testing and lay counselor follow up</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CD4 Referral &amp; Clinic Referral</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV positive persons not on ART at enrollment, randomized to referral for CD4 testing and referral to clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Circumcision - SMS Reminder</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV negative uncircumcised males, randomized to SMS reminder for male circumcision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Circumcision - Lay Counselor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV negative uncircumcised males, randomized to lay counselor follow-up for male circumcision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Circumcision - Promotion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV negative uncircumcised males, randomized to promotion of male circumcision at the time of HIV testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>POC VL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV positive persons on ART, randomized to POC viral load testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laboratory based VL assay</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV positive persons on ART, randomized to laboratory based viral load testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>POC CD4 Testing</intervention_name>
    <description>Point of Care CD4 testing</description>
    <arm_group_label>POC CD4 &amp; Clinic Accompaniment</arm_group_label>
    <arm_group_label>POC CD4 &amp; Lay Counselor</arm_group_label>
    <arm_group_label>POC CD4 &amp; Clinic Referral</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CD4 Referral</intervention_name>
    <description>Referral to CD4 testing</description>
    <arm_group_label>CD4 Referral &amp; Clinic Accompaniment</arm_group_label>
    <arm_group_label>CD4 Referral &amp; Lay Counselor</arm_group_label>
    <arm_group_label>CD4 Referral &amp; Clinic Referral</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lay Counselor Follow-up</intervention_name>
    <description>Follow-up from a lay counselor</description>
    <arm_group_label>POC CD4 &amp; Lay Counselor</arm_group_label>
    <arm_group_label>CD4 Referral &amp; Lay Counselor</arm_group_label>
    <arm_group_label>Circumcision - Lay Counselor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Clinic Accompaniment</intervention_name>
    <description>Accompaniment to the clinic by a counselor</description>
    <arm_group_label>POC CD4 &amp; Clinic Accompaniment</arm_group_label>
    <arm_group_label>CD4 Referral &amp; Clinic Accompaniment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Clinic Referral</intervention_name>
    <description>Referral to clinic</description>
    <arm_group_label>POC CD4 &amp; Clinic Referral</arm_group_label>
    <arm_group_label>CD4 Referral &amp; Clinic Referral</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS Reminder</intervention_name>
    <description>SMS reminder for male circumcision</description>
    <arm_group_label>Circumcision - SMS Reminder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Circumcision Promotion</intervention_name>
    <description>Promotion of male circumcision at the time of HIV testing</description>
    <arm_group_label>Circumcision - Promotion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>POC VL</intervention_name>
    <description>POC VL testing for HIV infected persons on ART</description>
    <arm_group_label>POC VL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory based VL assay</intervention_name>
    <description>Laboratory based viral load testing for HIV infected persons on ART</description>
    <arm_group_label>Laboratory based VL assay</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Reside in the study community

          -  Must be 16 years or older

          -  Able and willing to provide informed consent/assent for study procedures

          -  HIV negative uncircumcised men must be age 16 - 49 years and have access to  secure
             text messaging to be randomized to strategies for male circumcision.

        Exclusion Criteria:

          -  N/A
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Connie Celum, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Connie Celum, MD,MPH</last_name>
    <phone>206-520-3825</phone>
    <email>ccelum@uw.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ruanne Barnabas, MBChB, DPhil</last_name>
    <phone>(206) 520-3813</phone>
    <email>rbarnaba@uw.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Human Sciences Research Council (HSRC)</name>
      <address>
        <city>Sweetwaters</city>
        <state>KwaZulu Natal</state>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Van Rooyen, BA, PhD</last_name>
      <phone>+27 33 324 1102</phone>
      <email>HvanRooyen@hsrc.ac.za</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intergrated Community Based Initivatives (ICOBI)</name>
      <address>
        <city>Kabwohe</city>
        <state>Bushenyi</state>
        <country>Uganda</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elioda Tumwesigye, MBChB, MS</last_name>
      <phone>+256 772 489 632</phone>
      <email>elioda@kcrc.or.ug</email>
    </contact>
  </location>
  <location_countries>
    <country>South Africa</country>
    <country>Uganda</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>January 14, 2014</lastchanged_date>
  <firstreceived_date>December 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Connie Celum</investigator_full_name>
    <investigator_title>Professor of Medicine, Epidemiology and Global Health</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>HIV Counseling and Testing</keyword>
  <keyword>Linkages to Care</keyword>
  <keyword>Point of Care CD4</keyword>
  <keyword>Point of Care Viral Load</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>HIV Antibodies</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
